Myferon 150 Forte
NDC Package 58607-112-00

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was inactivated by the FDA.

Myferon 150 Forte is indicated for the prevention and treatment of iron deficiency anemia and/or nutritional megaloblastic anemias. Marketed by Martin Ekwealor Pharmaceuticals, Inc., this product is identified by NDC 58607-112.

Identification & Billing

NDC Package Code
58607-112-00
Package Description
100 BLISTER PACK in 1 BOX / 10 CAPSULE in 1 BLISTER PACK
Product Code
58607-112
11-Digit Billing Format
58607011200
Billing Unit
EA - Billing unit of "each" is used when the product is dispensed in discreet units.
Units Per Package
100 EA
RxNorm Crosswalk
  • RxCUI: 309606 - polysaccharide iron complex (iron) 150 MG / folic acid 1 MG / vitamin B12 25 MCG Oral Capsule
  • RxCUI: 309606 - folic acid 1 MG / polysaccharide iron complex 150 MG / vitamin B12 0.025 MG Oral Capsule
  • RxCUI: 309606 - cyanocobalamin 25 MCG / folic acid 1 MG / polysaccharide iron complex 150 MG Oral Capsule
  • RxCUI: 309606 - folate 1 MG / polysaccharide iron complex 150 MG / vitamin B12 0.025 MG Oral Capsule

Clinical Specifications

Proprietary Name
Myferon 150 Forte
Dosage Form
-
Usage Information
Myferon 150 Forte is indicated for the prevention and treatment of iron deficiency anemia and/or nutritional megaloblastic anemias.

Regulatory & Marketing

Labeler Name
Martin Ekwealor Pharmaceuticals, Inc.
Marketing Category
UNAPPROVED DRUG OTHER - An unapproved drug product in a marketing category that is not reflected on a particular list.
Start Marketing Date
12-01-1996
Listing Expiration
12-31-2017
Exclude Flag
I
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 58607-112-00 identifies a specific commercial package of 100 blister pack in 1 box / 10 capsule in 1 blister pack of Myferon 150 Forte, labeled by Martin Ekwealor Pharmaceuticals, Inc.. This product is billed for "EA" each discreet unit and contains an estimated amount of 100 billable units per package. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Martin Ekwealor Pharmaceuticals, Inc. on December 01, 1996. The current certification is valid through December 31, 2017.

How is this Martin Ekwealor Pharmaceuticals, Inc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 58607011200. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 100 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
58607-112-00
11-Digit CMS (5-4-2)
58607-0112-00

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.